TELK

Telik Inc

Clinical-stage biopharmaceutical company developing small molecule oncology drugs

2008 Q22 of 5 quarters

Total Value

$1.26M

Total Shares

1.04M

Net Share Change

0

Activity

No changes

Investor

Value

Shares

Weight

Change

Icahn Capital LP

$1.26M

1.04M

0.0%

Unchanged

Major holders (13D/G) →